Updated efficacy and safety results from phase 1 and phase 2 studies for AVR-RD-01, an investigational lentiviral gene therapy for Fabry disease

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

Original languageEnglish
Pages (from-to)S119-S119
Number of pages1
JournalMolecular Genetics and Metabolism
Issue number2
Publication statusPublished - Feb 2022
Externally publishedYes
Event18th Annual WORLD Symposium - San Diego, Canada
Duration: 7 Feb 202211 Feb 2022

Cite this